- Corporate Officers - G
- George Jean
Insider Trading History of George Jean
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of George Jean since 2015.
This trader's CIK number is 1291804.
At the time of last reporting, George Jean was the Officer of Shoulder Innovations, Inc.. (stock ticker symbol SI).
Also see all insider trading activities at Shoulder Innovations, Inc..
Note that in the past
George Jean also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Zeltiq Aesthetics Inc (ZLTQ) by George Jean
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | ZLTQ | 0 | $0 | 17,483 | $511,482 | 17,483 | $99,653 |
Yearly summary of insider trading at Astria Therapeutics, Inc. (CATB) by George Jean
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2015 | CATB | 258,776 | $3,105,312 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cyteir Therapeutics, Inc. (CYT) by George Jean
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | CYT | 0 | $0 | 0 | $0 | 14,150 | $23,913 |
Yearly summary of insider trading at Acceleron Pharma Inc (XLRN) by George Jean
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | XLRN | 0 | $0 | 37,500 | $1,492,242 | 37,500 | $1,028,137 |
| 2017 | XLRN | 0 | $0 | 105,122 | $3,756,009 | 0 | $0 |
| 2016 | XLRN | 0 | $0 | 1,310,650 | $48,021,605 | 127,122 | $747,477 |
Yearly summary of insider trading at Shoulder Innovations, Inc. (SI) by George Jean
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | SI | 266,666 | $3,999,990 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by George Jean:
1. Zeltiq Aesthetics Inc (ZLTQ)
2. Astria Therapeutics, Inc. (CATB)
3. Cyteir Therapeutics, Inc. (CYT)
4. Acceleron Pharma Inc (XLRN)
5. Shoulder Innovations, Inc. (SI)
Table 1. Insider trading of Zeltiq Aesthetics Inc (ZLTQ) by George Jean
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-01-15 | ZLTQ | Option Ex | 17,483 | 5.70 | 99,653 |
| 2015-01-15 | ZLTQ | Sale | 17,483 | 29.26 | 511,482 |
Table 2. Insider trading of Astria Therapeutics, Inc. (CATB) by George Jean
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2015-06-30 | CATB | Buy | 258,776 | 12.00 | 3,105,312 |
Table 3. Insider trading of Cyteir Therapeutics, Inc. (CYT) by George Jean
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-02-14 | CYT | Option Ex | 14,150 | 1.69 | 23,913 |
Table 4. Insider trading of Acceleron Pharma Inc (XLRN) by George Jean
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-06-26 | XLRN | Sale | 25,688 | 39.16 | 1,005,942 |
| 2019-06-28 | XLRN | Sale | 11,812 | 41.17 | 486,300 |
| 2019-06-26 | XLRN | Option Ex | 37,500 | 27.42 | 1,028,137 |
| 2017-12-15 | XLRN | Sale | 105,122 | 35.73 | 3,756,009 |
| 2016-12-07 | XLRN | Option Ex | 127,122 | 5.88 | 747,477 |
| 2016-11-16 | XLRN | Sale | 32,929 | 41.39 | 1,362,931 |
| 2016-11-17 | XLRN | Sale | 420,576 | 38.59 | 16,230,027 |
| 2016-09-30 | XLRN | Sale | 857,145 | 35.50 | 30,428,647 |
Table 5. Insider trading of Shoulder Innovations, Inc. (SI) by George Jean
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-08-01 | SI | Buy | 266,666 | 15.00 | 3,999,990 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by George Jean
(Officer of Shoulder Innovations, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.